Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Bluebird Bio Inc (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2014	12-2013	12-2012	12-2011	12-2006
Cash Flows From Operating Activities
Net Income	-48,709	-25,321	-23,670	-15,598	N/A
Depreciation Amortization	4,228	941	301	225	N/A
Accounts payable and accrued liabilities	-2,249	2,067	380	870	N/A
Other Working Capital	-14,734	60,890	1,521	1,932	N/A
Other Operating Activity	1,771	4,873	424	354	0
Operating Cash Flow	$-59,693	$43,450	$-21,044	$-12,217	$N/A

Cash Flows From Investing Activities
Change In Deposits	-144,021	0	3,506	-3,526	N/A
PPE Investments	-8,708	-8,670	-867	-403	N/A
Net Acquisitions	-4,673	N/A	N/A	N/A	N/A
Other Investing Activity	209	-1,153	-40	-35	0
Investing Cash Flow	$-157,193	$-9,823	$2,599	$-3,964	$N/A

Cash Flows From Financing Activities
Common Stock Issued	358,452	105,297	21	1	N/A
Other Financing Activity	0	344	59,831	32,434	0
Financing Cash Flow	$358,452	$105,641	$59,852	$32,435	$N/A

Beginning Cash Position	206,279	67,011	25,604	9,350	N/A
End Cash Position	347,845	206,279	67,011	25,604	N/A
Net Cash Flow	$141,566	$139,268	$41,407	$16,254	$N/A

Free Cash Flow
Operating Cash Flow	-59,693	43,450	-21,044	-12,217	N/A
Capital Expenditure	-8,708	-8,670	-867	-403	N/A
Free Cash Flow	-68,401	34,780	-21,911	-12,620	0